- Home
- NCL vs CLGN Comparison
NCL vs CLGN Comparison
Compare NCL & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCL
- CLGN
- Stock Information
- Founded
- NCL 2013
- CLGN 2004
- Country
- NCL United States
- CLGN Israel
- Employees
- NCL N/A
- CLGN N/A
- Industry
- NCL
- CLGN Industrial Specialties
- Sector
- NCL
- CLGN Health Care
- Exchange
- NCL Nasdaq
- CLGN Nasdaq
- Market Cap
- NCL 21.7M
- CLGN 19.1M
- IPO Year
- NCL 2023
- CLGN N/A
- Fundamental
- Price
- NCL $0.19
- CLGN $2.31
- Analyst Decision
- NCL
- CLGN Strong Buy
- Analyst Count
- NCL 0
- CLGN 2
- Target Price
- NCL N/A
- CLGN $11.50
- AVG Volume (30 Days)
- NCL 3.4M
- CLGN 70.3K
- Earning Date
- NCL 08-13-2025
- CLGN 08-19-2025
- Dividend Yield
- NCL N/A
- CLGN N/A
- EPS Growth
- NCL N/A
- CLGN N/A
- EPS
- NCL N/A
- CLGN N/A
- Revenue
- NCL $14,192,050.00
- CLGN $2,472,000.00
- Revenue This Year
- NCL N/A
- CLGN $1,999.42
- Revenue Next Year
- NCL N/A
- CLGN $69.81
- P/E Ratio
- NCL N/A
- CLGN N/A
- Revenue Growth
- NCL N/A
- CLGN N/A
- 52 Week Low
- NCL $0.15
- CLGN $1.31
- 52 Week High
- NCL $1.52
- CLGN $5.45
- Technical
- Relative Strength Index (RSI)
- NCL 42.03
- CLGN 65.19
- Support Level
- NCL $0.17
- CLGN $2.16
- Resistance Level
- NCL $0.21
- CLGN $2.28
- Average True Range (ATR)
- NCL 0.01
- CLGN 0.18
- MACD
- NCL 0.02
- CLGN 0.11
- Stochastic Oscillator
- NCL 62.27
- CLGN 86.24
About NCL Northann Corp.
Northann Corp specialized in 3D-printed flooring solutions under its flagship brand, "Benchwick." The company's operations span the full spectrum of additive manufacturing, from sourcing recycled ocean plastics to the final production of intricate flooring designs. Northann offers an extensive range of proprietary solutions, including Infinite Glass, DSE, TruBevel, and MattMaster, primarily through its sales network in North America and Europe.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.